Horkovics-Kovats S - Search Results

1

Comparison of dissolution time profiles: No similarity but where is the difference?

Horkovics-Kovats S. Horkovics-Kovats S. Eur J Pharm Sci. 2018 Aug 30;121:9-15. doi: 10.1016/j.ejps.2018.05.017. Epub 2018 May 18. Eur J Pharm Sci. 2018. PMID: 29782910

2

Population data analysis of dissolution time profiles: Assessment of physicochemical properties of the drug, drug particles and the pharmaceutical formulation.

Horkovics-Kovats S, Brunovský P, Pichler A, Bulitta JB. Horkovics-Kovats S, et al. Eur J Pharm Sci. 2015 Oct 12;78:245-54. doi: 10.1016/j.ejps.2015.07.017. Epub 2015 Jul 26. Eur J Pharm Sci. 2015. PMID: 26215465

3

Disintegration rate and properties of active pharmaceutical ingredient particles as determined from the dissolution time profile of a pharmaceutical formulation: an inverse problem.

Horkovics-Kovats S. Horkovics-Kovats S. J Pharm Sci. 2014 Feb;103(2):456-64. doi: 10.1002/jps.23767. Epub 2013 Dec 11. J Pharm Sci. 2014. PMID: 24338791

4

Dissolution and coarsening of polydisperse, polymorph drug particles liberated from a disintegrating finished dosage form: Theoretical considerations.

Horkovics-Kovats S. Horkovics-Kovats S. Eur J Pharm Sci. 2016 Aug 25;91:265-77. doi: 10.1016/j.ejps.2016.05.003. Epub 2016 May 4. Eur J Pharm Sci. 2016. PMID: 27155254

5

Physicochemical pharmacokinetics as an optimization tool for generic development: A case study.

Horkovics-Kovats S, Ulč I, Vít L, Němec B, Rada V. Horkovics-Kovats S, et al. Eur J Pharm Sci. 2018 Jan 1;111:349-357. doi: 10.1016/j.ejps.2017.10.018. Epub 2017 Oct 13. Eur J Pharm Sci. 2018. PMID: 29032305 Clinical Trial.

6

Raman-based real-time dissolution prediction using a deterministic permeation model.

Horkovics-Kovats S, László Galata D, Zlatoš P, Nagy B, Alexandra Mészáros L, Kristóf Nagy Z. Horkovics-Kovats S, et al. Int J Pharm. 2022 Apr 5;617:121624. doi: 10.1016/j.ijpharm.2022.121624. Epub 2022 Feb 26. Int J Pharm. 2022. PMID: 35231548 Free article.

7

Characterization of an active pharmaceutical ingredient by its dissolution properties: amoxicillin trihydrate as a model drug.

Horkovics-Kovats S. Horkovics-Kovats S. Chemotherapy. 2004 Nov;50(5):234-44. doi: 10.1159/000081944. Epub 2004 Nov 3. Chemotherapy. 2004. PMID: 15528889

8

Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans.

Kim TH, Shin S, Landersdorfer CB, Chi YH, Paik SH, Myung J, Yadav R, Horkovics-Kovats S, Bulitta JB, Shin BS. Kim TH, et al. Among authors: horkovics kovats s. AAPS J. 2015 Sep;17(5):1210-23. doi: 10.1208/s12248-015-9764-2. Epub 2015 May 20. AAPS J. 2015. PMID: 25990964 Free PMC article. Clinical Trial.

9

Lack of Male-Female Differences in Disposition and Esterase Hydrolysis of Ramipril to Ramiprilat in Healthy Volunteers after a Single Oral Dose.

Vree TB, Dammers E, Ulc I, Horkovics-Kovats S, Ryska M, Merkx I. Vree TB, et al. ScientificWorldJournal. 2003 Dec 11;3:1344-1358. doi: 10.1100/tsw.2003.122. eCollection 2003. ScientificWorldJournal. 2003. PMID: 29887764 Free PMC article.

10

Differences between lovastatin and simvastatin hydrolysis in healthy male and female volunteers:gut hydrolysis of lovastatin is twice that of simvastatin.

Vree TB, Dammers E, Ulc I, Horkovics-Kovats S, Ryska M, Merkx I. Vree TB, et al. ScientificWorldJournal. 2003 Dec 11;3:1332-43. doi: 10.1100/tsw.2003.121. ScientificWorldJournal. 2003. PMID: 14755114 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters